PPT-Lung Cancer Detection by Breath Analysis

Michael Bousamra II Director of Thoracic Surgery Floyd Memorial Hospital KentuckyIndiana Cancer Registrars Meeting September 8 2016 The Lung Cancer Problem Lung Cancer is the leading cause of cancer death in the United States. It affects about one in 20 children This event is distressing and frightening to witness but does not cause any shortterm or longterm harm to your child Boys and girls are equally affected The spells usually start before 18 months of age and stop by Albert A. Rizzo, MD FACP FCCP. Section Chief Pulmonary/ Critical Care Medicine. Christiana Care Health System, Newark De. &. Immediate Past-Chair. National Board of Directors . American Lung Association. What it is & what you need to know. What is lung cancer?. 2 types:. 1. Non-small cell lung cancer (NSCLC). 85% of cases. 2. Small cell lung cancer -10%-15% of all lung cancer cases. . Symptoms of lung cancer. Participating Institutions. : . Case Western Reserve University; University of Washington; University of Iowa; University of North Carolina; University of South Carolina; University of Kentucky; CDC; NCI. L. CHRISTINE OLIVER, MD, MPH, MS. COLLEGIUM RAMAZZINI. OCTOBER 28, 2016. BERNARDINO RAMAZZINI 1713. DR. RAMAZZINI 1713. QUOTED HIPPOCRATES FROM . AFFECTIONS. :. “WHEN YOU COME TO A PATIENT’S HOUSE, YOU SHOULD ASK HIM WHAT SORT OF PAINS HE HAS, WHAT CAUSED THEM, HOW MANY DAYS HE HAS BEEN ILL.”. By: Cindy . Stegman. RN BSN. Alverno. College MSN 621. Spring 2010. stegmacm@alverno.edu. How to navigate this tutorial:. To advance to next slide click on box. To advance to previous slide click on box. Lung cancer. What does this have to do with BRG1?. LOH . in chromosome 19 is frequent in NSLC tumors. BRG1 . is very frequently inactivated in lung tumors. . (as many as 1/3 of NSCLC cell lines have mutations in BRG1). Table of Contents. 1. Lung Cancer Summary. 2. Types of Lung Cancer. 3. Types of Lung Cancer continued. 4.Diagnostic Imaging. 5.Risk Factors. 6.Symptoms. 7. Conditions. 8.Diagnostic and Testing. 9. Diagnostic and testing continued. Lei Zhao. 1*. , . Marco Lequio. 2,3*. , . Ziwen. Zhu. 3. , . Huaping. Xiao. 2,4. , Jacob Lee. 3. , . Tianru. Shi. 2. , Qian Bai. 3. , Aldo G. Dominguez. 3. , Mark R. Wakefield. 3. , . Yujiang. Fang. May 4, 2016. 12:30 p.m. – 2:00 p.m. ET. Sponsored by: . Agency for Healthcare Research and Quality (AHRQ). 2. SHARE Approach Webinar Series. Webinar 5. Shared Decision Making Tools for . Lung Cancer Screening. Roberto Cardarelli, DO, MPH, FAAFP. Professor of Family and Community Medicine. Chief of the Division of Community Medicine. Director, Kentucky Ambulatory Network. 1. Kentucky Cancer Consortium. June 19, 2015. Non - small Locally Advanced Daniel W. Golden MD, PGY - 5, Ryan Bair MD, PGY - 3, and Matthew Koshy MD, Assistant Professor Pritzker School of Medicine, University of Chicago Chicago Clinical Presen Lung Cancer: Medical Aspects of Causation. Aneuploidy. Unlimited cell reproduction and failure of cell death. Animal Studies. Basic Toxicology. New Data on Causation. New Studies. New Statistics. Number of cases. Contributed by:. Harini. S, Intern, . TCS Research, Pune, India . Mr. . Parijat. . Deshpande. , . Senior Scientist, . TCS Research, Pune, India. Dr. . Beena. . Rai. , . Head Physical Sciences Research, .